Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Cybercrime in 2025 has evolved into a full‑scale service economy, with malware now available through subscription platforms that operate like mainstream tech businesses. Bitsight’s latest analysis reveals explosive growth in Malware‑as‑a‑Service tools, rising attacks across industries like healthcare, finance, tech, and real estate, and a surge in cross‑platform malware and supply‑chain exploits. For professionals in any licensed field, the message is clear: today’s digital landscape demands heightened vigilance, stronger identity security, and proactive defense against an increasingly organized underground threat environment.
A new proptech startup in the UAE, Gllit is redefining how property deals happen by removing agents, eliminating commissions, and integrating AI tools that let users create professional listings in seconds. With a fast, transparent, and direct-to-owner model, Gllit offers a glimpse into the future of global real estate — and a powerful case study for U.S. professionals preparing for tech-driven changes in the industry.
The 2026 housing market is shaping up to be a year of stability with a few surprises. Mortgage rates are expected to hold steady, home price growth is slowing, and yet ownership costs continue to rise due to soaring taxes and insurance. Meanwhile, renting is becoming more attractive as affordability improves and built‑to‑rent communities expand. This breakdown highlights the biggest trends ahead — and what they mean for buyers, sellers, and real estate professionals, especially in Florida.
Florida homeowners are facing some of the highest insurance premiums in the nation, with average costs now topping $5,800 per year—about $3,000 above the U.S. average. Many residents report their rates have doubled or even tripled, while more than 40 percent of claims are closed with no payment. As frustration grows, state lawmakers and consumer advocates are pushing for transparency, rate caps, and incentives to help storm‑proof homes. The outcome of these reform efforts could reshape Florida’s real estate market, insurance landscape, and affordability for years to come.
A new global study from Risk.net and SAS reveals that many insurance companies are still making key decisions in isolated silos, despite industry-wide pushes toward data-driven strategies. While most leaders claim to have a clear vision, 38 percent admit they lack a real-time view of risks, revenue and costs. With poor data quality, limited collaboration and outdated processes holding teams back, experts say the industry is poised for a major transformation through AI, analytics and unified strategy—offering lessons for professionals across insurance, real estate, finance and other regulated fields.
Atlanta’s housing market is shifting into a more balanced and predictable phase. Prices have leveled off, inventory has finally caught up, and mortgage rates are easing enough to bring buyers back into the game. With steady demand, growing listings, and only mild price corrections forecasted into 2026, Atlanta remains one of the Southeast’s strongest real estate markets for buyers, sellers, and investors alike.
